How blood cell production differs in CLL, MBL, and healthy people
Part of Blood & lymphatic, Cancer, Immune system & allergy clinical trials.
This trial studies how the body makes blood cells in people with chronic lymphocytic leukemia (CLL), a related condition called monoclonal B-cell lymphocytosis (MBL), and in healthy volunteers matched by age. The goal is to understand differences that may help improve treatment or monitoring.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 40 years or older.
- You may have CLL (chronic lymphocytic leukemia) — whether you are untreated, currently being treated, or have been treated in the past.
- You may have MBL (monoclonal B-cell lymphocytosis), a condition that can be a precursor to CLL.
- You may be a healthy adult without CLL or MBL.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study measures how your body’s metabolism works in people with chronic lymphocytic leukemia (CLL). It uses blood tests, and for some people, a bone marrow sample, to better understand what’s happening and potentially guide future treatments.
This study follows people with certain slow-growing blood cancers (CLL/SLL, LPL/WM, and related conditions) to understand how they progress and what leads to needing treatment. It may help doctors predict changes over time and plan care more effectively.
This study looks at families where more than one person has a blood cell disorder (lymphoproliferative disorder) to understand why it runs in families. If you or a relative have this condition, you may help researchers learn more about it.
This is a study that looks back and forward at people diagnosed with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), or a related early condition called MBL. It aims to improve how these conditions are recognized and managed over time in Italy.
This study looks at people with a small number of abnormal B-cells in their blood to understand if those cells increase the risk of developing blood cancers. If you're over 40 and haven't had a blood-related cancer diagnosis, you might be eligible to participate and help researchers learn more about this condition.
This study aims to learn more about chronic lymphocytic leukemia (CLL) and closely related conditions. It may help researchers better understand who gets CLL and how it behaves over time, which can improve future care.
Hear when a new Chronic Lymphocytic Leukemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.